The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Interleukin‐10 prevents experimental allergic encephalomyelitis in rats
Abstract
Experimental allergic encephalomyelitis (EAE) is an autoimmune disease mediated by myelin protein‐specific CD4+ T lymphocytes of the T h 1‐like phenotype. In rats, the disease is characterized by a monophasic clinical manifestation, followed by a subsequent spontaneous remission and the establishment of life‐long resistance to reinduction of disease. Recent data indicate that intracerebral cytokine production, in particular synthesis of interleukin(IL)‐10, is selectively up‐regulated during the recovery phase of disease. This led us to assess the effects of IL‐10 on different rat lymphoid cell functions in vitro and to consider the possibility of an IL‐10‐mediated treatment to prevent the induction of central nervous system (CNS) autoimmune disease in vivo. Human recombinant IL‐10 suppressed interferon‐γ induced major histocompatibility complex class II up‐regulation in rat peritoneal macrophages, exhibited pleiotropic effects on thymocytes and totally abrogated tumor necrosis factor production of encephalitogenic T lymphocytes in vitro, without simultaneously affecting proliferative responses of the cells. Upon systemic administration during the initiation phase of disease, IL‐10 was effective in markedly suppressing the subsequent induction of EAE in Lewis rats. This suppression of clinical disease coincided with a significant and specific elevation of myelin basic protein‐specific autoantibody production, a sustained T cell proliferative response to myelin basic protein and a diminution of CNS infiltrations and thymic involutions in diseased animals. These data implicate IL‐10 as a possible candidate for treatment of T h 1‐mediated CNS (auto‐) immune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.579 · Cited by 1,009
Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.547 · Cited by 796
Interleukin 10 protects mice from lethal endotoxemia.
Howard, M., Muchamuel, T., Andrade, S., & Menon, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1205 · Cited by 792
The role of IL-10 in crossregulation of TH1 and TH2 responses
Mosmann, T. R., & Moore, K. W. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80015-5 · Cited by 768
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3299 · Cited by 556
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 532
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B. M., Dwyer, B. K., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 469
Strategies for use of IL‐10 or its antagonists in human disease
O'Garra, A., Barrat, F. J., Castro, A. G., Vicari, A., & Hawrylowicz, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00635.x · Cited by 452
Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis
Secor, V. H., Secor, W. E., Gutekunst, C.-A., & Brown, M. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.813 · Cited by 430
BETHEA, J. R., NAGASHIMA, H., ACOSTA, M. C., BRICENO, C., GOMEZ, F., MARCILLO, A. E., LOOR, K., GREEN, J., & DIETRICH, W. D. (1999) · Journal of Neurotrauma · doi:10.1089/neu.1999.16.851 · Cited by 401
Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
Liva, S. M., & Voskuhl, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2060 · Cited by 394
CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis
Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K., & Khoury, S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5228 · Cited by 370
Hohlfeld, R. (1997) · Brain · doi:10.1093/brain/120.5.865 · Cited by 365
Duchmann, R., Schmitt, E., Knolle, P., Zum Büschenfelde, K. M., & Neurath, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260432 · Cited by 345
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Saxena, A., Khosraviani, S., Noel, S., Mohan, D., Donner, T., & Hamad, A. R. A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.10.031 · Cited by 306
Inhibition of autoimmune encephalomyelitis by a tetracycline
Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D. (2002) · Annals of Neurology · doi:10.1002/ana.10092 · Cited by 295
“may also contribute directly to the suppression of disease activity.(19) Moreover, the decrease in the MOGspecific antibody response induced by minocycline, in particular, of those IgG2 isotypes that are efficient activators of the complement cascade, will reduce the pathogenic capacity of the humoral response to MOG.”
BackgroundMolecular mechanisms of interleukin-10-mediated inhibition of NF-κ B activity: a role for p50
DRIESSLER, F., VENSTROM, K., SABAT, R., ASADULLAH, K., & SCHOTTELIUS, A. J. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02342.x · Cited by 269
Estriol ameliorates autoimmune demyelinating disease: Implications for multiple sclerosis
Kim, S., Liva, S. M., Dalal, M. A., Verity, M. A., & Voskuhl, R. R. (1999) · Neurology · doi:10.1212/wnl.52.6.1230 · Cited by 268
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
Holdsworth, S. R., Kitching, A. R., & Tipping, P. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00369.x · Cited by 262
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Sex Hormones in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis
Voskuhl, R. R., & Palaszynski, K. (2001) · The Neuroscientist · doi:10.1177/107385840100700310 · Cited by 158
Ko, K. S., Lee, M., Koh, J. J., & Kim, S. W. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0459 · Cited by 97
CHADBAN, TESCH, FOTI, LAN, ATKINS, & NIKOLIC‐PATERSON (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00487.x · Cited by 44
Metadata
- Authors
- Rott, O., Fleischer, B., & Cash, E.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1994-06
- Volume
- 24
- Issue
- 6
- Pages
- 1434-1440
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2062794300
- Cited by
- 367
- References
- 29
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.